IP Library › Assignment 075071/0515
Patent Assignment
Reel/Frame 075071/0515

Security Interest

Recorded: 2026-06-24 Pages: 9
Assignor
4D MOLECULAR THERAPEUTICS, INC.
Executed: 2026-06-24
Assignee
HERCULES CAPITAL, INC., AS AGENT
1 NORTH B STREET, SUITE 2000, SAN MATEO, CALIFORNIA, 94401
Covered Properties (32)
Codon Optimized RPGRORF15 Genes and Uses Thereof
Application: 18/042,517 →
Publication: US 2023/0340042
Codon Optimized REP1 Genes and Uses Thereof
Application: 18/052,735 →
Publication: US 2023/0158172
Adeno-Associated Virus Variant Capsids with Improved Retinal Transduction and Uses Thereof
Application: 18/447,866 →
Publication: US 2024/0066145
Adeno-Associated Virus Variant Capsids and Use for Inhibiting Angiogenesis
Application: 18/466,517 →
Publication: US 2024/0335560
Adeno-Associated Variants, Formulations and Methods for Pulmonary Delivery
Application: 18/468,142 →
Publication: US 2024/0067987
Codon Optimized REP1 Genes and Uses Thereof
Application: 18/766,963 →
Publication: US 2024/0358859
Compositions and Methods for Treatment of Ocular Disease Associated with Angiogenesis
Application: 18/767,370 →
Publication: US 2025/0057987
Adeno-Associated Virus Variant Capsids with Improved Lung Tropism and Uses Thereof
Application: 18/844,861 →
Publication: US 2026/0014275
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 18/978,736 →
Publication: US 2025/0163469
Adeno-Associated Virus Variant Capsids with Improved Retinal Transduction and Uses Thereof
Application: 19/301,643 →
Publication: US 2026/0053947
Aav Variants for Treatment of Complement Disorders
Application: 19/473,440 →
Novel Complement System Inhibiting Antibodies
Application: 19/485,517 →
Adeno-Associated Virus Formulations
Application: 19/490,178 →
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 16/300,446 →
Publication: US 2019/0255192
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 16/648,195 →
Publication: US 2020/0248205
Adeno-Associated Virus Variant Capsids and Use for Inhibiting Angiogenesis
Application: 16/765,758 →
Publication: US 2020/0282077
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 16/951,984 →
Publication: US 2021/0069348
Method of Using Adeno-Associated Virus with Variant Capsid
Application: 16/952,002 →
Publication: US 2021/0069349
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 17/163,093 →
Publication: US 2021/0162071
Codon Optimized Gla Genes and Uses Thereof
Application: 17/240,948 →
Publication: US 2021/0332341
Adeno-Associated Variants, Formulations and Methods for Pulmonary Delivery
Application: 17/241,032 →
Publication: US 2021/0395772
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 17/400,041 →
Publication: US 2021/0380643
Codon Optimized RPGRORF15 Genes and Uses Thereof
Application: 17/461,716 →
Publication: US 2022/0064673
Codon Optimized REP1 Genes and Uses Thereof
Application: 17/463,262 →
Publication: US 2022/0062438
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 17/718,870 →
Publication: US 2022/0251145
Codon Optimized REP1 Genes and Uses Thereof
Application: 17/740,045 →
Publication: US 2022/0265860
Treatments for Retinal Disease
Application: 17/746,443 →
Publication: US 2023/0001018
Adeno-Associated Variants, Formulations and Methods for Pulmonary Delivery
Application: 17/938,641 →
Publication: US 2023/0257772
Codon Optimized Gla Genes and Uses Thereof
Application: 18/045,650 →
Publication: US 2023/0190964
Treatments for Retinal Disease
Application: 18/069,347 →
Publication: US 2023/0211013
Adeno-Associated Virus Variant Capsids and Methods of Use Thereof
Application: 18/069,701 →
Publication: US 2023/0279435
Treatments for Ocular Neovascularization
Application: 19/300,498 →
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 24, 2020
From: KIRN, DAVID H.; KOTTERMAN, MELISSA A.; SCHAFFER, DAVID; SZYMANSKI, PAUL
To: 4D MOLECULAR THERAPEUTICS INC.
Reel/Frame 053877/0092 →